Hyperfine, Inc. (HYPR)
0.7437
-0.04
(-5.21%)
USD |
NASDAQ |
Oct 29, 12:18
Hyperfine Enterprise Value : 51.85M for Oct. 28, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 28, 2026 | 51.85M |
| October 27, 2026 | 48.15M |
| October 26, 2026 | 45.34M |
| October 23, 2026 | 45.47M |
| October 22, 2026 | 45.61M |
| October 21, 2026 | 47.79M |
| October 20, 2026 | 50.73M |
| October 19, 2026 | 51.07M |
| October 16, 2026 | 48.69M |
| October 15, 2026 | 51.37M |
| October 14, 2026 | 53.49M |
| October 13, 2026 | 58.94M |
| October 12, 2026 | 64.77M |
| October 09, 2026 | 67.34M |
| October 08, 2026 | 68.34M |
| October 07, 2026 | 58.68M |
| October 06, 2026 | 60.91M |
| October 05, 2026 | 62.27M |
| October 02, 2026 | 63.43M |
| October 01, 2026 | 61.09M |
| September 30, 2026 | 54.33M |
| September 29, 2026 | 54.01M |
| September 28, 2026 | 57.29M |
| September 25, 2026 | 54.89M |
| September 24, 2026 | 53.05M |
| Date | Value |
|---|---|
| September 23, 2026 | 52.42M |
| September 22, 2026 | 54.02M |
| September 21, 2026 | 51.48M |
| September 18, 2026 | 51.86M |
| September 17, 2026 | 50.60M |
| September 16, 2026 | 50.75M |
| September 15, 2026 | 53.61M |
| September 14, 2026 | 53.91M |
| September 11, 2026 | 52.43M |
| September 10, 2026 | 52.04M |
| September 09, 2026 | 52.52M |
| September 08, 2026 | 55.79M |
| September 04, 2026 | 54.89M |
| September 03, 2026 | 57.41M |
| September 02, 2026 | 54.12M |
| September 01, 2026 | 54.62M |
| August 31, 2026 | 56.06M |
| August 28, 2026 | 57.00M |
| August 27, 2026 | 58.30M |
| August 26, 2026 | 60.70M |
| August 25, 2026 | 60.88M |
| August 24, 2026 | 59.45M |
| August 21, 2026 | 64.31M |
| August 20, 2026 | 64.52M |
| August 19, 2026 | 64.28M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 205.26B |
| AngioDynamics, Inc. | 491.37M |
| Alphatec Holdings, Inc. | 2.257B |
| AtriCure, Inc. | 3.030B |
| Baxter International, Inc. | 19.84B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.298M |
| Revenue (Quarterly) | 3.904M |
| Total Expenses (Quarterly) | 13.20M |
| EPS Diluted (Quarterly) | -0.0932 |
| Gross Profit Margin (Quarterly) | 50.72% |
| Profit Margin (Quarterly) | -238.2% |
| Earnings Yield | -51.59% |
| Normalized Earnings Yield | -49.54 |